CNOP regimen
WikiDoc Resources for CNOP regimen |
Articles |
---|
Most recent articles on CNOP regimen Most cited articles on CNOP regimen |
Media |
Powerpoint slides on CNOP regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on CNOP regimen at Clinical Trials.gov Clinical Trials on CNOP regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on CNOP regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on CNOP regimen Discussion groups on CNOP regimen Patient Handouts on CNOP regimen Directions to Hospitals Treating CNOP regimen Risk calculators and risk factors for CNOP regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for CNOP regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:CNOP Regimen; Cytoxan-Novantrone-Oncovin-Prednisone Regimen; MCOP
Overview
CNOP regimen refers to a regimen consisting of cyclophosphamide, mitoxantrone (Novantrone), vincristine and prednisone used to treat both indolent and aggressive forms of non-Hodgkin's lymphoma.[1]
Regimen
CCyclophosphamide
NNovantrone (mitoxantrone)
OVincristine (oncovin)
PPrednisone